Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetic Neuropathy

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...

Glucose Transporters

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...

Hyperglycemia

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...

Hypoglycemia

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...

Hepatic Encephalopathy

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Students' and educators' perceptions of clinical academic pathways in the UK: a qualitative study.

BMJ open·2025

Same author

Long-term outcomes of ganglionated plexus ablation as sole therapy for paroxysmal atrial fibrillation.

Heart rhythm·2024

Same author

Experiences of the clinical academic pathway: a qualitative study in Greater Manchester to improve the opportunities of minoritised clinical academics.

BMJ open·2024

Same author

Errors of Interpretation - correcting the record on the comparative efficacy of surgical masks versus respirators.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2022

Same author

Radiofrequency ablation data associated with atrioesophageal fistula.

HeartRhythm case reports·2022

Same author

Ectopy-triggering ganglionated plexuses ablation to prevent atrial fibrillation: GANGLIA-AF study.

Heart rhythm·2021

Search research articles

Related Experiment Video

Updated: Jul 9, 2026

Measuring Uptake of the Glucose Analog, 6-(N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Amino)-6-Deoxyglucose, in Intact Murine Neural Retina

Measuring Uptake of the Glucose Analog, 6-(N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Amino)-6-Deoxyglucose, in Intact Murine Neural Retina

Published on: March 14, 2025

Glucose neurotoxicity.

David R Tomlinson¹, Natalie J Gardiner

¹Faculty of Life Sciences, University of Manchester, Oxford Road, Manchester, M13 9PT, UK. david.tomlinson@manchester.ac.uk

Nature Reviews. Neuroscience

|December 21, 2007

Summary

Neurons require constant glucose and cannot regulate it with insulin like muscle cells. Persistent high blood sugar (hyperglycemia) causes glucose neurotoxicity, explaining key aspects of diabetic neuropathy.

Area of Science:

Neuroscience
Endocrinology
Metabolic disorders

Background:

Neurons have a high, constant demand for glucose.
Unlike muscle cells, neurons do not uptake glucose episodically via insulin.
Extracellular glucose concentration directly impacts neuronal glucose uptake.

Purpose of the Study:

To review the pathophysiological effects of elevated glucose on neurons.
To explain how glucose neurotoxicity contributes to diabetic neuropathy.

Main Methods:

Literature review of pathophysiological mechanisms.
Analysis of glucose metabolism in neurons.
Correlation of hyperglycemic effects with diabetic neuropathy symptoms.

Main Results:

More Related Videos

A Neuronal and Astrocyte Co-Culture Assay for High Content Analysis of Neurotoxicity

A Neuronal and Astrocyte Co-Culture Assay for High Content Analysis of Neurotoxicity

Published on: May 5, 2009

Related Experiment Videos

Last Updated: Jul 9, 2026

Measuring Uptake of the Glucose Analog, 6-(N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Amino)-6-Deoxyglucose, in Intact Murine Neural Retina

Measuring Uptake of the Glucose Analog, 6-(N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Amino)-6-Deoxyglucose, in Intact Murine Neural Retina

Published on: March 14, 2025

A Neuronal and Astrocyte Co-Culture Assay for High Content Analysis of Neurotoxicity

A Neuronal and Astrocyte Co-Culture Assay for High Content Analysis of Neurotoxicity

Published on: May 5, 2009

Persistent hyperglycemia leads to glucose neurotoxicity.
This neurotoxicity damages neurons due to their unique glucose dependency.
The mechanisms of glucose neurotoxicity explain major diabetic neuropathy components.

Conclusions:

Understanding neuronal glucose metabolism is crucial for managing diabetic complications.
Glucose neurotoxicity is a key pathway in the development of diabetic neuropathy.
Targeting neuronal glucose regulation may offer therapeutic strategies for diabetic neuropathy.